Company: CI
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001739940-25-000009
Chunk: 41

Company: Cigna Group
Filing Date: 2025-02-27
Form: 10-K
Item: Item 2
Chunk 41
---
.99 4.30 Special itemsIntegration and transaction-related costs0.97 0.75 0.15 0.12 0.43 0.33 Impairment of dividend receivable 0.64 0.49 — — — — Deferred tax expenses (benefits), net— 0.30 — (3.61)— — Net (gain) loss on sale of businesses (0.08)(0.02)5.05 4.81 (5.31)(4.26)Charge for organizational efficiency plan— — 0.85 0.65 0.07 0.05 Charges (benefits) associated with litigation matters— — 0.68 0.58 (0.09)(0.06)Total special items$1.53 1.52 $6.73 2.55 $(4.90)(3.94)Adjusted income from operations$27.33 $25.09 $23.36 

(1)Includes Net investment gains/losses as presented in our Consolidated Statements of Income, as well as the Company's share of certain investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting, which are presented within Fees and other revenues in our Consolidated Statements of Income.

40

Financial highlights by segmentFor the Years Ended December 31,ChangeChange(Dollars in millions, except per share amounts)2024202320222024 vs. 20232023 vs. 2022RevenuesAdjusted revenues by segmentEvernorth Health Services$202,155 $153,499 $140,335 32 %9 %Cigna Healthcare52,914 51,205 45,037 3 14 Other Operations828 596 2,263 39 (74)Corporate, net of eliminations(8,798)(9,978)(6,991)(12)43 Adjusted revenues247,099 195,322 180,644 27 8 Net investment results from certain equity method investments204 (57)(126)N/M(55)Special item related to impairment of dividend receivable(182)— — N/MN/MTotal revenues$247,121 $195,265 $180,518 27 %8 %Shareholders' net income$3